ADMA Biologics Inc (ADMA)
Current ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 331,410 | 318,193 | 303,691 | 276,419 | 257,013 | 273,699 | 266,243 | 264,086 | 270,402 | 224,095 | 222,774 | 239,800 | 208,729 | 174,785 | 171,355 | 177,277 | 153,741 | 139,549 | 142,990 | 165,488 |
Total current liabilities | US$ in thousands | 55,542 | 44,891 | 44,177 | 53,088 | 49,806 | 41,841 | 41,952 | 36,728 | 39,267 | 44,440 | 28,072 | 31,567 | 30,378 | 32,337 | 18,186 | 21,206 | 19,947 | 16,474 | 12,880 | 13,908 |
Current ratio | 5.97 | 7.09 | 6.87 | 5.21 | 5.16 | 6.54 | 6.35 | 7.19 | 6.89 | 5.04 | 7.94 | 7.60 | 6.87 | 5.41 | 9.42 | 8.36 | 7.71 | 8.47 | 11.10 | 11.90 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $331,410K ÷ $55,542K
= 5.97
The current ratio of ADMA Biologics Inc has fluctuated over the past few years, indicating changes in the company's liquidity position. The current ratio measures the company's ability to cover its short-term liabilities with its short-term assets. ADMA Biologics Inc experienced a significant decline in its current ratio from a high of 11.90 on March 31, 2020, to a low of 5.04 on September 30, 2022, before gradually improving to 7.09 on September 30, 2024.
A current ratio above 1 indicates that a company can cover its short-term obligations with its current assets. Therefore, ADMA Biologics Inc has generally maintained a current ratio above 1 throughout the period, suggesting that the company has had sufficient current assets to meet its short-term liabilities.
However, a declining current ratio over time could signal potential liquidity challenges or inefficiencies in managing current assets and liabilities. Investors and creditors may view a decreasing current ratio with caution, as it may indicate a weakening financial position. It is important for ADMA Biologics Inc to continue monitoring its current ratio and implement strategies to maintain a healthy liquidity position.
Peer comparison
Dec 31, 2024